13F HOLDINGS REPORT
Aisling Capital Management LP
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0001766721-23-000004
Total Value
$242.7M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BridgeBio Pharma Inc. (BBIO) | BBIO | 6,068,125 | $160.0M | 65.94% |
| 2 | Verona Pharma plc (VRNA) | 925050106 | 1,115,352 | $18.2M | 7.49% |
| 3 | Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | 1,025,000 | $14.9M | 6.13% |
| 4 | Biomea Fusion Inc (BMEA) | BMEA | 798,757 | $11.0M | 4.53% |
| 5 | Compass Pathways Plc (CMPS) | CMPS | 964,500 | $7.1M | 2.94% |
| 6 | Monte Rosa Therapeutics Inc (GLUE) | GLUE | 1,472,331 | $7.1M | 2.91% |
| 7 | Reneo Pharmaceuticals Inc (RPHM) | 75974E103 | 886,075 | $6.7M | 2.78% |
| 8 | Nuvation Bio Inc. (NUVB) | NUVB | 2,541,009 | $3.4M | 1.40% |
| 9 | Aclaris Theraputics Inc (ACRS) | ACRS | 434,455 | $3.0M | 1.23% |
| 10 | Spruce Biosciences, Inc. (SPRB) | SPRB | 1,205,511 | $2.7M | 1.12% |
| 11 | Poseida Therapeutics Inc. (PSTX) | 73730P108 | 1,043,267 | $2.5M | 1.02% |
| 12 | Elevation Oncology Inc (ELEV) | 28623U101 | 2,834,910 | $1.9M | 0.77% |
| 13 | Avrobio, Inc. (AVRO) | 05455M100 | 1,009,779 | $1.6M | 0.64% |
| 14 | Marker Therapeutics, Inc. (MRKR) | MRKR | 314,286 | $1.4M | 0.59% |
| 15 | Aeglea Biotherapeutics Inc (AGLE) | SYRE | 67,645 | $828,652 | 0.34% |
| 16 | Viracta Therapeutics Inc (VIRX) | 92765F108 | 288,571 | $300,114 | 0.12% |
| 17 | Atreca Inc. (BCEL) | 04965G109 | 387,653 | $101,177 | 0.04% |